Biomanufacturing Media

  1. Characterizing Product- And Process-Related Impurities In Multispecifics 6/2/2025

    In this segment from the Bioprocess Online Live event, “Challenges And Considerations For Purifying Multispecific Molecules,” our panelists Mark Fitchmun and Dr. Jian Ren examine the types of common impurities manufacturers encounter in multispecific purification and explain the differences between product-related impurities and process-related impurities.

  2. Involve CMC And Formulations Experts Early In Process Development 6/2/2025

    In this segment from the Bioprocess Online Live event, “Challenges And Considerations For Purifying Multispecific Molecules,” our panelists talk about the cross-functional importance of formulations and CMC leads in process development.

  3. Successful Microbial Testing And Identification 5/27/2025

    In this presentation, one of our industry-leading customers discusses how they've successfully implemented the Applied Biosystems MicroSEQ Microbial Identification System in their laboratory testing.

  4. Optimize Your RNA-LNP Delivery With Ionizable Lipids 4/3/2025

    Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

  5. Key Considerations For Shortening Your CAR-T Manufacturing Process 3/31/2025

    Explore the development of an automated CAR-T cell therapy process using an innovative platform as well as learn strategies to optimize vein-to-vein time and enhance CAR-T cell shelf life for better patient outcomes.

  6. An Automated System For Rapid Manufacturing Of Engineered T-Cells 3/31/2025

    Discover an innovative TCT-LS process for CAR-T cell therapy that targets blood cancers, solid tumors, and infectious diseases, as well as learn about its unique features, limitations, and how it enhances strategies.

  7. Flow Cytometric Assays For CAR-T Cell Manufacturing 3/31/2025

    Join Dr. Stephen Wilmes, PhD, as he explores the critical role of flow cytometry in analyzing CAR-T cell products to focus on identity, purity, potency, and new technologies enhancing assay sensitivity.

  8. Antisense Oligonucleotide Extraction Optimization Reveals Differences 2/17/2025

    Our findings provide critical insights into refining ASO extraction protocols, which can enhance the accuracy of downstream analyses and support further research into ASO-based therapeutics.

  9. Tissue Adenosine Distribution-Guided Gene Selection 2/17/2025

    Unlike conventional predictive biomarkers, which often focus on isolated molecular markers, this strategy integrates spatial metabolomics and genomics, providing a multidimensional perspective.

  10. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

    Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.